abstract |
A method is described for treating a mammal having cancer and infection with a molecule having a functional activity of IL-21. Molecules having functional activity of IL-21 include polypeptides having homology to the polypeptide sequence of human IL-21 and proteins fused to polypeptides having functional activity of IL-21. These molecules can be used as a monotherapy or in combination with other known cancer or viral treatments. |